Please use this identifier to cite or link to this item: http://repository.tma.uz/xmlui/handle/1/5944
Full metadata record
DC FieldValueLanguage
dc.contributor.authorNuruzova Z.A., Jumamurodov S.T.-
dc.date.accessioned2023-01-20T12:11:32Z-
dc.date.available2023-01-20T12:11:32Z-
dc.date.issued2020-12-
dc.identifier.issn14039 - 14048-
dc.identifier.urihttp://repository.tma.uz/xmlui/handle/1/5944-
dc.description.abstractThe article presents the results of a bacteriological study of H. pylori strains isolated from patients with gastric MALT lymphoma treated in cancer centers in the city of Tashkent. Antibiotic resistance was detected by the disk diffusion method for first-line drugs used in the eradication therapy of H. pylori strains: amoxicillin, clarithromycin, levofloxacin, metronidazole, tetracycline, as well as doxycycline, rifampicin and chloramphenicol. A high level of resistance to chloramphenicol, doxycycline and rifampicin was revealed. There was an increase in resistance to metronidazole (20% of strains), amoxicillin (17.7%) and clarithromycin (15.6% of resistant strains), i.e. on the border of permissible limits, which dictates the need for an individual approach to caradication therapy, with the obligatory bacteriological isolation of the pathogen to determine antibiotic resistance.en_US
dc.language.isoenen_US
dc.publisherUSAen_US
dc.subjectHelicobacter pylori, bacteriological research, antibiotic resistance, eradication therapy.en_US
dc.titleResistance to Antibacterial Preparations of H. Pylori, Allocated in Patients With (Malt) Gastric Lymphomaen_US
dc.title.alternativeResistance to Antibacterial Preparations of H. Pylori, Allocated in Patients With (Malt) Gastric Lymphomaen_US
dc.typeArticleen_US
Appears in Collections:Thesis, Articles

Files in This Item:
File Description SizeFormat 
SOP011b-ITM_CTP_Real-time_PCR.docx.pdf323.32 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.